At a glance
ClinicalIndex Comparison RecordN/ACompleted· 369 enrolled
Drug / intervention
IOLdevice
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
A Multi-center, Prospective Clinical Trial to Evaluate the Safety and Effectiveness of a Posterior Chamber Intraocular Lens for Correction of Aphakia Following Cataract Removal
In Brief
A clinical study evaluating IOL for Cataract Unilateral and Aphakia. Completed, enrolled 369 participants across 1 site.
Detailed Summary
To establish the safety and effectiveness of the CT LUCIA 611P posterior chamber intraocular lens for the correction of aphakia following extracapsular cataract extraction via phacoemulsification in adult patients.
Study Details
Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsCataract Unilateral, Aphakia
CountriesUnited States
Collaborators--
Timeline
N/ACompletedFinished
201820192020202120222023202420252026
First PostedMar 2018
Enrollment StartApr 2018
Primary CompletionMar 2020
TodayJul 2026
First PostedMar 2, 2018
Enrollment StartApr 23, 2018
Primary CompletionMar 12, 2020
TodayJul 2, 2026
Enrollment to primary: 1.9 yearsPosted 8.3 years ago
Interventions
IOLdevice
Intraocular lens